litlas
Log inCreate account

Madeleine Duvic

Active 1979–2025

166
Papers
32,033
Citations
103
h-index
163
i10-index

Citations

Citations per year for Madeleine Duvic1981: 1 citations1982: 2 citations1983: 1 citations1984: 1 citations1985: 3 citations1986: 3 citations1987: 3 citations1988: 5 citations1989: 21 citations1990: 17 citations1991: 15 citations1992: 26 citations1993: 25 citations1994: 25 citations1995: 23 citations1996: 33 citations1997: 43 citations1998: 41 citations1999: 60 citations2000: 62 citations2001: 63 citations2002: 98 citations2003: 111 citations2004: 107 citations2005: 112 citations2006: 142 citations2007: 198 citations2008: 176 citations2009: 211 citations2010: 229 citations2011: 221 citations2012: 222 citations2013: 207 citations2014: 224 citations2015: 232 citations2016: 181 citations2017: 272 citations2018: 207 citations2019: 797 citations2020: 906 citations2021: 893 citations2022: 557 citations2023: 465 citations2024: 594 citations2025: 280 citations2026: 5 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,483 citing papers, 30.9% of this breakdownGermany: 519 citing papers, 6.5% of this breakdownChina: 516 citing papers, 6.4% of this breakdownUnited Kingdom: 509 citing papers, 6.3% of this breakdownItaly: 412 citing papers, 5.1% of this breakdownFrance: 359 citing papers, 4.5% of this breakdownJapan: 251 citing papers, 3.1% of this breakdownCanada: 241 citing papers, 3% of this breakdownSpain: 224 citing papers, 2.8% of this breakdownAustralia: 215 citing papers, 2.7% of this breakdownSwitzerland: 196 citing papers, 2.5% of this breakdownNetherlands: 183 citing papers, 2.3% of this breakdown
0%30.9%Other 23.9%

Institutions

Fields

  • Medicine61.1%
  • Biochemistry, Genetics and Molecular Biology27.2%
  • Immunology and Microbiology8.9%
  • Pharmacology, Toxicology and Pharmaceutics0.5%
  • Engineering0.5%
  • Computer Science0.3%
  • Other1.5%

Topics

  • Cutaneous lymphoproliferative disorders research7%
  • Lymphoma Diagnosis and Treatment5.3%
  • Histone Deacetylase Inhibitors Research3.9%
  • Hair Growth and Disorders3.2%
  • CAR-T cell therapy research2.6%
  • Dermatology and Skin Diseases2.3%
  • Other75.7%

Coauthors

All papers

Open in search
  1. Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial

    Authors: Youn H. Kim, M. Bagot, Lauren Pinter‐Brown, Alain H. Rook, Pierluigi Porcu, Sarah McCue Horwitz, Sean Whittaker, Y. Tokura, Maarten H. Vermeer, Pier Luigi Zinzani, Lubomir Sokol, Stephen Morris, Ellen J. Kim, Pablo L. Ortiz‐Romero, Herbert Eradat, Julia Scarisbrick, Athanasios Tsianakas, Craig A. Elmets, Stéphane Dalle, David C. Fisher, Ahmad Halwani, Brian Poligone, John P. Greer, Maria Teresa Fierro, Amit Khot, Alison J. Moskowitz, Amy Musiek, Andrei R. Shustov, Barbara Pro, Larisa J. Geskin, Karen M. Dwyer, Junji Moriya, Mollie Leoni, Jeffrey S. Humphrey, Stacie Hudgens, Dmitri O. Grebennik, Kensei Tobinai, Madeleine Duvic, Sunil Abhyankar, Oleg E. Akilov, Önder Alpdoğan, M. Beylot‐Barry, Erin Boh, Dolores Caballero, Richard Cowan, Brigitte Dréno, Reinhard Dummer, Timothy S. Fenske, Francine Foss, Noriko Fukuhara, Pratyush Giri, Koji Habe, Toshihisa Hamada, Kiyohiko Hatake, Shinsuke Iida, Osamu Ishikawa, Lars Iversen, Eiji Kiyohara, Hiroshi Koga, Neil J. Korman, Bryone J. Kuss, Zanetta S. Lamar, Frederick Lansigan, Mary Jo Lechowicz, Adam Lerner, Nina Magnolo, Lawrence A. Mark, Tomomitsu Miyagaki, Javier Muñoz, Jan P. Nicolay, Kaoru Nishiwaki, Hiroyuki Okamoto, Mikio Ohtsuka, Theresa Pacheco, Christiane Querfeld, Ronald Peter Rapini, Shigetoshi Sano, Maiko Tanaka, Michael D. Tharp, Jiro Uehara, Hidefumi Wada, Jillian Wells, Ryan A. Wilcox, Basem M. William, Kentaro Yonekura - The Lancet Oncology 2018 cited by 645

  2. Alopecia areata investigational assessment guidelines–Part II

    Authors: Elise A. Olsen, Maria K. Hordinsky, Vera H. Price, Janet L. Roberts, Jerry Shapiro, Doug Canfield, Madeleine Duvic, Lloyd E. King, Amy McMichael, Valerie A. Randall, Maria L. Turner, Leonard C. Sperling, David A. Whiting, David A. Norris - Journal of the American Academy of Dermatology 2004 cited by 786

  3. Cobomarsen, an oligonucleotide inhibitor of miR‐155, co‐ordinately regulates multiple survival pathways to reduce cellular proliferation and survival in cutaneous T‐cell lymphoma

    Authors: Anita G. Seto, Xuan Beatty, Joshua M. Lynch, Melanie Hermreck, Michael T. Tetzlaff, Madeleine Duvic, Aimee L. Jackson - British Journal of Haematology 2018 cited by 315

  4. Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell Neoplasm

    Authors: Naveen Pemmaraju, Andrew A. Lane, Kendra Sweet, Anthony S. Stein, Sumithira Vasu, William Blum, David A. Rizzieri, Eunice S. Wang, Madeleine Duvic, J. Mark Sloan, Sharon Spence, Shay Shemesh, Christopher Brooks, John Balser, Ivan Bergstein, Jeffrey E. Lancet, Hagop M. Kantarjian, Marina Konopleva - New England Journal of Medicine 2019 cited by 417

  5. Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial

    Authors: H. Miles Prince, Youn H. Kim, Sarah McCue Horwitz, Reinhard Dummer, Julia Scarisbrick, Pietro Quaglino, Pier Luigi Zinzani, Pascal Wolter, José Antônio Sanches, Pablo L. Ortiz‐Romero, Oleg E. Akilov, Larisa J. Geskin, Judith Trotman, Kerry Taylor, Stéphane Dalle, Michael Weichenthal, Jan Walewski, David C. Fisher, Brigitte Dréno, Rudolf Stadler, Tatyana Feldman, Timothy M. Kuzel, Yinghui Wang, Maria Corinna Palanca-Wessels, Erin Zagadailov, William L. Trepicchio, Wenwen Zhang, Huimin Lin, Yi Liu, Dirk Huebner, Meredith Little, Sean Whittaker, Madeleine Duvic, Judith Trotman, David Joske, H. Miles Prince, Kerry Taylor, Ian D. Lewis, Constanze Jonak, Franz Trautinger, Oliver Bechter, Pascal Wolter, Dominique Bron, Vladmir Cláudio Cordeiro de Lima, José Antônio Sanches, Richard Klasa, M. Bagot, M. Beylot‐Barry, Stéphane Dalle, M. D’Incan, Brigitte Dréno, Florent Grange, Jan P. Nicolay, Rudolf Stadler, Michael Weichenthal, Marion Wobser, Chalid Assaf, Carmen Loquai, Pietro Quaglino, Michele Spina, Pier Luigi Zinzani, Alberto Bosi, Pier Paolo Fattori, Aleksandra Grzanka, Jan Walewski, Andrés López‐Hernandez, Pablo L. Ortiz‐Romero, José J. Rifón Roca, Silvana Novelli Canales, Reinhard Dummer, Tim Illidge, Rod Johnson, Sean Whittaker, Stephen Morris, Pam McKay, Julia Scarisbrick, Madeleine Duvic, Tatyana Feldman, Oleg E. Akilov, Larisa J. Geskin, Steve Horwitz, Youn H. Kim, Barbara Pro, Timothy M. Kuzel, Adam Lerner, Herbert Eradat, Lubomir Sokol, David C. Fisher, S. Morgan Hughey - The Lancet 2017 cited by 580

  6. Genome-wide association study in alopecia areata implicates both innate and adaptive immunity

    Authors: Lynn Petukhova, Madeleine Duvic, Maria Hordinsky, David A. Norris, Vera H. Price, Yutaka Shimomura, Hyunmi Kim, Pallavi Singh, Annette Lee, Wei V. Chen, Katja C. Meyer, Ralf Paus, Colin A.B. Jahoda, Christopher I. Amos, Peter K. Gregersen, Angela M. Christiano - Nature 2010 cited by 828

  7. Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)

    Authors: Elise A. Olsen, Eric C. Vonderheid, Nicola Pimpinelli, Rein Willemze, Youn Kim, Robert Knobler, Herschel Zackheim, Madeleine Duvic, Teresa Estrach, Stanford Lamberg, Gary S. Wood, Reinhard Dummer, Annamari Ranki, Günter Burg, Peter Heald, Mark R. Pittelkow, M.G. Bernengo, Wolfram Sterry, L. Laroche, Franz Trautinger, Sean Whittaker - Blood 2007 cited by 1,416

  8. Guidelines of care for the management of primary cutaneous melanoma

    Authors: Christopher K. Bichakjian, Allan C. Halpern, Timothy M. Johnson, Antoinette F. Hood, James M. Grichnik, Susan M. Swetter, Hensin Tsao, Victoria Barbosa, Tsu-Yi Chuang, Madeleine Duvic, Vincent Ho, Arthur J. Sober, Karl R. Beutner, Reva Bhushan, Wendy Smith Begolka - Journal of the American Academy of Dermatology 2011 cited by 616

  9. Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC

    Authors: Elise A. Olsen, Sean Whittaker, Rein Willemze, Lauren Pinter‐Brown, Francine M. Foss, Larisa J. Geskin, Lawrence Schwartz, Sarah McCue Horwitz, Joan Guitart, John A. Zic, Youn H. Kim, Gary S. Wood, Madeleine Duvic, Wei Ai, Michael Girardi, Alejandro A. Gru, Emmanuella Guenova, Emmilia Hodak, Richard T. Hoppe, Werner Kempf, Ellen Kim, Mary Jo Lechowicz, Pablo L. Ortiz‐Romero, Evangelia Papadavid, Pietro Quaglino, Mark R. Pittelkow, H. Miles Prince, José Antônio Sanches, Makoto Sugaya, Maarten H. Vermeer, Jasmine M. Zain, Robert Knobler, Rudolf Stadler, M. Bagot, Julia Scarisbrick - Blood 2021 cited by 171

  10. Phase IIB Multicenter Trial of Vorinostat in Patients With Persistent, Progressive, or Treatment Refractory Cutaneous T-Cell Lymphoma

    Authors: Elise A. Olsen, Youn H. Kim, Timothy M. Kuzel, Theresa Pacheco, Francine M. Foss, Sareeta Parker, Stanley R. Frankel, Cong Chen, Justin L. Ricker, Jean Marie Arduino, Madeleine Duvic - Journal of Clinical Oncology 2007 cited by 1,048

  11. Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)

    Authors: Madeleine Duvic, Rakshandra Talpur, Xiao Ni, Chunlei Zhang, Parul Hazarika, Cecilia Kelly, Judy H. Chiao, John F. Reilly, Justin L. Ricker, Victoria M. Richon, Stanley R. Frankel - Blood 2006 cited by 1,137

  12. Discovery and clinical introduction of first-in-class imipridone ONC201

    Authors: Joshua E. Allen, C. Leah B. Kline, Varun V. Prabhu, Jessica Wagner, Jo Ishizawa, Neel S. Madhukar, Avital Lev, Marie Baumeister, Lanlan Zhou, Amriti R. Lulla, Martin Stogniew, Lee Schalop, Cyril H. Benes, Howard L. Kaufman, Richard S. Pottorf, Bhaskara Rao Nallaganchu, Gary L. Olson, Fahd Al‐Mulla, Madeleine Duvic, Gen Sheng Wu, David T. Dicker, Mala K. Talekar, Bora Lim, Olivier Elemento, Wolfgang Oster, Joseph Bertino, Keith T. Flaherty, Michael Wang, Gautam Borthakur, Michael Andreeff, Mark N. Stein, Wafik S. El‐Deiry - Oncotarget 2016 cited by 166

  13. Clinical End Points and Response Criteria in Mycosis Fungoides and Sézary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer

    Authors: Elise A. Olsen, Sean Whittaker, Youn H. Kim, Madeleine Duvic, H. Miles Prince, Stuart R. Lessin, Gary S. Wood, Rein Willemze, Marie‐France Demierre, Nicola Pimpinelli, Maria Grazia Bernengo, Pablo L. Ortiz‐Romero, M. Bagot, Teresa Estrach, Joan Guitart, Robert Knobler, José Antônio Sanches, Keiji Iwatsuki, Makoto Sugaya, Reinhard Dummer, Mark R. Pittelkow, Richard T. Hoppe, Sareeta Parker, Larisa J. Geskin, Lauren Pinter‐Brown, Michael Girardi, Günter Burg, Annamari Ranki, Maarten H. Vermeer, Sarah McCue Horwitz, Peter Heald, Steven T. Rosen, Lorenzo Cerroni, Brigette Dréno, Eric C. Vonderheid - Journal of Clinical Oncology 2011 cited by 658

  14. Diverse types of dermatologic toxicities from immune checkpoint blockade therapy

    Authors: Jonathan L. Curry, Michael T. Tetzlaff, Priyadharsini Nagarajan, Carol R. Drucker, Adi Diab, Sharon R. Hymes, Madeleine Duvic, Wen‐Jen Hwu, Jennifer A. Wargo, Carlos A. Torres‐Cabala, Ronald P. Rapini, Víctor G. Prieto - Journal of Cutaneous Pathology 2016 cited by 228

  15. Final Results From a Multicenter, International, Pivotal Study of Romidepsin in Refractory Cutaneous T-Cell Lymphoma

    Authors: Sean Whittaker, Marie‐France Demierre, Ellen J. Kim, Alain H. Rook, Adam Lerner, Madeleine Duvic, Julia Scarisbrick, Sunil Reddy, Tadeusz Robak, Jürgen C. Becker, А. В. Самцов, William McCulloch, Youn H. Kim - Journal of Clinical Oncology 2010 cited by 661

  16. Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model

    Authors: Julia Scarisbrick, H. Miles Prince, Maarten H. Vermeer, Pietro Quaglino, Sarah McCue Horwitz, Pierluigi Porcu, Rudolf Stadler, Gary S. Wood, M. Beylot‐Barry, Anne Pham‐Ledard, Francine M. Foss, Michael Girardi, M. Bagot, Laurence Michel, Maxime Battistella, Joan Guitart, Timothy M. Kuzel, Maria Estela Martínez‐Escala, Teresa Estrach, Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, Vassilki Nikolaou, Makoto Sugaya, Tomomitsu Miyagaki, Robert Gniadecki, José Antônio Sanches, Jade Cury‐Martins, Denis Miyashiro, Octavio Servitje, Cristina Muniesa, Emilio Berti, Francesco Onida, Laura Corti, Emilia Hodak, Iris Amitay‐Laish, Pablo L. Ortiz‐Romero, José Luis Rodríguez‐­Peralto, Robert Knobler, Stefanie Porkert, Wolfgang Bauer, Nicola Pimpinelli, Vieri Grandi, Richard Cowan, Alain H. Rook, Ellen Kim, Alessandro Pileri, Annalisa Patrizi, Ramón M. Pujol, Henry K. Wong, Kelly Tyler, René Stranzenbach, Christiane Querfeld, Paolo Fava, Milena Maule, Rein Willemze, Felicity Evison, Stephen Morris, Robert Twigger, Rakhshandra Talpur, Jinah Kim, G. Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, Madeleine Duvic, Sean Whittaker, Youn H. Kim - Journal of Clinical Oncology 2015 cited by 421

  17. Randomized phase 3 ALCANZA study of brentuximab vedotin vs physician’s choice in cutaneous T-cell lymphoma: final data

    Authors: Sarah McCue Horwitz, Julia Scarisbrick, Reinhard Dummer, Sean Whittaker, Madeleine Duvic, Youn H. Kim, Pietro Quaglino, Pier Luigi Zinzani, Oliver Bechter, Herbert Eradat, Lauren Pinter‐Brown, Oleg E. Akilov, Larisa J. Geskin, José Antônio Sanches, Pablo L. Ortiz‐Romero, Michael Weichenthal, David C. Fisher, Jan Walewski, Judith Trotman, Kerry Taylor, Stéphane Dalle, Rudolf Stadler, Julie Lisano, Veronica Bunn, Meredith Little, H. Miles Prince - Blood Advances 2021 cited by 114

  18. Response to Brentuximab Vedotin by CD30 Expression in Non-Hodgkin Lymphoma

    Authors: Deepa Jagadeesh, Steve Horwitz, Nancy L. Bartlett, Youn Kim, Eric D. Jacobsen, Madeleine Duvic, Meredith Little, William L. Trepicchio, Keenan Fenton, Matthew Onsum, Julie Lisano, Ranjana H. Advani - The Oncologist 2022 cited by 49

  19. North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need

    Authors: Naveen Pemmaraju, Hagop M. Kantarjian, Kendra Sweet, Eunice S. Wang, Jayastu Senapati, Nathaniel R. Wilson, Marina Konopleva, Arthur E. Frankel, Vikas Gupta, Ruben A. Mesa, Matthew L. Ulrickson, Edward J. Gorak, Sumeet Bhatia, Tülin Budak-Alpdoǧan, James R. Mason, María Teresa García‐Romero, Norma López‐Santiago, Gabriela Cesarman‐Maus, Pankit Vachhani, Sangmin Lee, Vijaya Raj Bhatt, William Blum, Roland B. Walter, Dale L. Bixby, Ivana Gojo, Madeleine Duvic, Raajit K. Rampal, Marcos de Lima, James M. Foran, Amir T. Fathi, Aric C. Hall, Meagan A. Jacoby, Jeffrey E. Lancet, Gabriel N. Mannis, Anthony S. Stein, Alice S. Mims, David A. Rizzieri, Rebecca L. Olin, Alexander E. Perl, Gary J. Schiller, Paul J. Shami, Richard M. Stone, Stephen A. Strickland, Matthew J. Wieduwilt, Naval Daver, Farhad Ravandi, Sumithira Vasu, Mónica L. Guzmán, Gail J. Roboz, Joseph D. Khoury, Muzaffar H. Qazilbash, Phyu P. Aung, Branko Cuglievan, Yazan F. Madanat, Mohamed A. Kharfan‐Dabaja, Anna Pawłowska, Justin Taylor, Martin S. Tallman, Prajwal Dhakal, Andrew A. Lane - Blood 2022 cited by 56

  20. Genomic profiling of Sézary syndrome identifies alterations of key T cell signaling and differentiation genes

    Authors: Linghua Wang, Xiao Ni, Kyle R. Covington, Betty Yang, Jessica Shiu, Xiang Zhang, Xi Liu, Qingchang Meng, Timothy Langridge, Jennifer Drummond, Lawrence A. Donehower, HarshaVardhan Doddapaneni, Donna M. Muzny, Richard A. Gibbs, David A. Wheeler, Madeleine Duvic - Nature Genetics 2015 cited by 323

  21. Tazarotene-induced Gene 2 (TIG2), a Novel Retinoid-Responsive Gene in Skin

    Authors: Sunil Nagpal, Sheetal Patel, Heidi Jacobe, Daniel DiSepio, Corine Ghosn, Monica Malhotra, Min Teng, Madeleine Duvic, Roshantha A.S. Chandraratna - Journal of Investigative Dermatology 1997 cited by 298

  22. Phase 1/2 study of mogamulizumab, a defucosylated anti-CCR4 antibody, in previously treated patients with cutaneous T-cell lymphoma

    Authors: Madeleine Duvic, Lauren Pinter‐Brown, Francine M. Foss, Lubomir Sokol, Jeffrey L. Jorgensen, Pramoda Challagundla, Karen M. Dwyer, Xiaoping Zhang, Michael R. Kurman, Rocco Ballerini, Li Liu, Youn H. Kim - Blood 2015 cited by 231

  23. A Phase II trial of Belinostat ( PXD 101) in patients with relapsed or refractory peripheral or cutaneous T‐cell lymphoma

    Authors: Francine M. Foss, Ranjana H. Advani, Madeleine Duvic, Kenneth B. Hymes, Tanin Intragumtornchai, Arnuparp Lekhakula, Ofer Shpilberg, Adam Lerner, Robert J. Belt, Eric D. Jacobsen, Guy Laurent, Dina Ben‐Yehuda, M. Beylot‐Barry, Uwe Hillen, Poul Knoblauch, Gajanan Bhat, Shanta Chawla, Lee F. Allen, Brad Pohlman - British Journal of Haematology 2014 cited by 190

  24. Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium

    Authors: Pietro Quaglino, Milena Maule, H. Miles Prince, Pierluigi Porcu, Sarah McCue Horwitz, Madeleine Duvic, R. Talpur, Maarten H. Vermeer, M. Bagot, Joan Guitart, Evangelia Papadavid, José Antônio Sanches, Emmilia Hodak, Makoto Sugaya, Emilio Berti, Pablo L. Ortiz‐Romero, Nicola Pimpinelli, Octavio Servitje, Alessandro Pileri, Pier Luigi Zinzani, Teresa Estrach, Robert Knobler, Rudolf Stadler, Maria Teresa Fierro, Silvia Alberti Violetti, Iris Amitay‐Laish, C. Antoniou, Chiara Astrua, Sridhar Chaganti, Fiona Child, Andrea Combalía, Stephanie K. Fabbro, Paolo Fava, Vieri Grandi, Constanze Jonak, Estela Martínez-Escala, Meenal Kheterpal, E.J. Kim, Christopher McCormack, Tomomitsu Miyagaki, Denis Miyashiro, Stephen Morris, Cristina Muniesa, Vasiliki Nikolaou, G. Ognibene, Francesco Onida, Simona Osella‐Abate, Stefanie Porkert, Concepción Postigo‐Llorente, C. Ram‐Wolff, Simone Ribero, Kortney Rogers, Martina Sanlorenzo, René Stranzenbach, Natalie Spaccarelli, Andrew Stevens, Daniela Zugna, Alain H. Rook, Larisa J. Geskin, Rein Willemze, Sean Whittaker, Richard T. Hoppe, Julia Scarisbrick, Y. Kim - Annals of Oncology 2017 cited by 136